On October 13, 2026—National Metastatic Breast Cancer Awareness Day—the world will literally change color. As night falls, over 325 iconic landmarks spanning 50 U.S. states, 20 countries, and 195 cities will be bathed in a glow of teal, green, and pink. This synchronized illumination, known as #LightUpMBC, is not merely a visual spectacle; it is a profound, coordinated act of advocacy designed to pierce the veil of silence surrounding Stage 4 metastatic breast cancer (MBC).
While October is widely recognized as Breast Cancer Awareness Month, the nuances of the disease are often lost in the broader conversation. The #LightUpMBC campaign, spearheaded by the non-profit organization METAvivor, aims to refocus public attention on the most lethal form of the disease: Stage 4 metastatic breast cancer. With no current cure, the reality for patients is a lifelong journey of treatment, uncertainty, and a relentless push for scientific advancement.
The Reality of Stage 4: Defining the Invisible Struggle
To understand the urgency of the #LightUpMBC movement, one must first understand the clinical reality of metastatic breast cancer. MBC occurs when cancer cells spread from the breast to distant organs—most commonly the bones, lungs, liver, or brain. Crucially, it remains classified as breast cancer even when found in these other sites.
For many, the diagnosis is a shock; some patients are diagnosed at Stage 4 from the very beginning, a condition known as de novo metastatic breast cancer. For others, the disease manifests months, years, or even decades after they were told their initial breast cancer had been treated and effectively put into remission.
The prevailing public narrative of "finishing treatment" or "winning the battle" often alienates the MBC community. For those living with Stage 4, treatment is never truly finished. It is a chronic, ongoing process of controlling the spread, extending life, and striving to maintain quality of life. Because cancer cells are remarkably adaptable, they often develop resistance to standard therapies, forcing patients to endure a revolving door of treatments, each with its own set of side effects and physical tolls.
The statistics are sobering. In the United States alone, an estimated 42,670 people are expected to lose their lives to breast cancer in 2026. This translates to approximately 117 deaths every single day—a figure that serves as a harrowing reminder of the critical, unmet need for innovative research.
Chronology: From a Single Light to a Global Movement
The #LightUpMBC campaign has roots in deep, personal loss. The movement was founded by Laura Inahara, whose best friend, Jessica Moore, passed away from metastatic breast cancer at the age of 36.
- 2017: The movement began with a singular, humble ambition: to illuminate one local landmark. Portsmouth’s Memorial Bridge in New Hampshire became the first landmark to light up in the official colors of MBC, marking the inception of what would become a global phenomenon.
- 2018–2024: The campaign gained momentum, expanding from a local tribute into a national effort. By leveraging social media and the power of patient-led advocacy, the organizers successfully recruited more cities and iconic structures each year.
- 2025: The campaign achieved unprecedented international reach, with landmarks in over a dozen countries joining the initiative.
- 2026: The current year marks a record-breaking expansion, with over 325 landmarks participating. From the One World Trade Center in New York and the Willis Tower in Chicago to the Ness Bridge in Scotland and the Mactan-Cebu Airport in the Philippines, the reach of the campaign has truly gone global.
This rapid growth illustrates a shift in the way the public engages with cancer advocacy: moving away from passive awareness and toward active, visible participation.
Supporting Data: Why Targeted Research Matters
METAvivor stands apart in the non-profit landscape because it exclusively funds Stage 4 metastatic breast cancer research. The organization operates under the firm belief that while early detection is vital, the survival of the 117 people dying daily depends entirely on new, transformative therapies that can turn a terminal diagnosis into a manageable, long-term condition.
The research selection process is intentionally rigorous. METAvivor employs a scientific peer-review board that works in tandem with patient advocates. This dual-layer oversight ensures that the funded projects are not only scientifically sound but also directly address the most pressing needs of the patient community.
To date, the #LightUpMBC campaign has raised over $2.7 million for this critical research. These funds are used to fill gaps in federal funding, which historically has prioritized early-stage cancer research over the complex, costly, and difficult science required to tackle metastatic disease.
Voices of the Community: Leadership and Legacy
The leadership behind METAvivor and the #LightUpMBC campaign consists of individuals who are not just advocates, but also patients. Their personal experiences provide the emotional core of the movement.
Dr. Kelly Shanahan, the current Board President of METAvivor, has been living with a metastatic diagnosis since 2013. "When I was diagnosed in 2013, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan reflects. Her survival, she notes, is directly tied to the scientific breakthroughs made possible by research. "My hope and the hope of so many others lies in research. #LightUpMBC is the biggest contributor to this work, and it is a way to bring us together as a community."
Founder Laura Inahara emphasizes that the campaign is designed to empower. "Jessica [Moore] hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love, teaches patients how to advocate for themselves, and has raised millions for research."
The #LightUpMBC Live Experience
The centerpiece of the awareness day is the #LightUpMBC Live broadcast, a free virtual event that blends education, storytelling, and high-production entertainment.
Scheduled for October 13 at 8 p.m. ET / 5 p.m. PT, the broadcast will be hosted by Tami Eagle Bowling, who has lived with MBC for 11 years, and Broadway performer and breast cancer survivor Kara Lindsay. The program will be accessible via the METAvivor YouTube channel, Facebook Live, and the LiveOne streaming platform.
Viewers can expect a deeply human experience. The broadcast will feature:
- Live segments: Direct reports from various illuminated landmarks where patients share their personal stories.
- Scientific insight: Experts will explain the latest developments in metastatic research and why these specific projects offer the most promise.
- Musical performances: A curated lineup of talent, including two-time Tony Award winner Victoria Clark, Tony Award nominee Dorian Harewood, actress Christina Bianco, singer-songwriter Cassandra Kubinski, and legendary voiceover artist Tony Daniels.
The goal of the broadcast is to educate the public while providing a sense of solidarity for the hundreds of thousands of people currently living with the disease.
Implications: The Path Toward a Survivable Future
The implications of the #LightUpMBC movement are twofold: social and clinical.
Socially, the campaign serves to dismantle the stigma and isolation that often accompany a Stage 4 diagnosis. By turning landmarks into beacons of teal, green, and pink, the organizers are forcing the public to look at a disease that is often hidden. It encourages conversation, fosters community among patients, and serves as a powerful tribute to those whose lives were cut short.
Clinically, the campaign is a direct engine for progress. Every dollar raised through the event goes toward research. In the world of oncology, funding often dictates the speed of discovery. By providing consistent, dedicated capital to high-impact projects, METAvivor is shortening the timeline for when new, life-extending therapies might reach the clinic.
As October 13 approaches, the message is clear: Awareness is only the first step. The true goal is to transform the narrative of metastatic breast cancer from one of terminal decline to one of sustained life.
For those looking to participate, the call to action is simple: take a photo of an illuminated landmark, share it on social media with the tags #LightUpMBC and #METAVIVOR, and tune in to the live broadcast. As the lights go up across the globe, the hope is that the visibility of the cause will eventually lead to the one thing that matters most: a cure.
For more information on participating landmarks, to find donation opportunities, or to access the live stream, visit www.lightupmbc.org.
About the Author
